These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 28509725)
21. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study. Sung KC; Oh YS; Cha DH; Hong SJ; Won KH; Yoo KD; Rha SW; Ahn YK; Ahn JC; Jang JY; Hong TJ; Cho SK; Park SH; Hyon MS; Nam CW; Chae IH; Yoo BS; Song JM; Jeong JO; Yoon YW; Kim BS; Yang TH; Cho DK; Kim SH; Choi YJ; Ahn JH; Jeon DW; Kim HS Clin Ther; 2018 Jan; 40(1):50-63.e3. PubMed ID: 29248384 [TBL] [Abstract][Full Text] [Related]
22. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension. White WB; Davidai G; Schumacher H J Hum Hypertens; 2009 Dec; 23(12):817-25. PubMed ID: 19357698 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension. Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457 [TBL] [Abstract][Full Text] [Related]
24. Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension. Neutel JM; Frishman WH; Oparil S; Papademitriou V; Guthrie G Am J Ther; 1999 May; 6(3):161-6. PubMed ID: 10423659 [TBL] [Abstract][Full Text] [Related]
25. Salt supplementation blunts the blood pressure response to telmisartan with or without hydrochlorothiazide in hypertensive patients with type 2 diabetes. Ekinci EI; Thomas G; MacIsaac RJ; Johnson C; Houlihan C; Panagiotopoulos S; Premaratne E; Hao H; Finch S; O'Callaghan C; Jerums G Diabetologia; 2010 Jul; 53(7):1295-303. PubMed ID: 20372874 [TBL] [Abstract][Full Text] [Related]
26. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial. White WB; Murwin D; Chrysant SG; Koval SE; Davidai G; Guthrie R Blood Press Monit; 2008 Feb; 13(1):21-7. PubMed ID: 18199920 [TBL] [Abstract][Full Text] [Related]
28. Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension. Jayaram S; Lahoti S; Chandrasekharan S; Ganesan R; Muralidharan RS; Mishra AB; Sodhi SS; Rajadhyaksha GC; Jain SD; Kadam GS; Gawde A; Desai A J Indian Med Assoc; 2004 Sep; 102(9):525-7. PubMed ID: 15887845 [TBL] [Abstract][Full Text] [Related]
29. Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation. Fogari R; Preti P; Zoppi A; Corradi L; Pasotti C; Rinaldi A; Mugellini A Am J Hypertens; 2005 May; 18(5 Pt 1):577-83. PubMed ID: 15882537 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of a single-pill combination of telmisartan/hydrochlorothiazide 80/25 mg in Chinese and Korean patients with moderate to severe hypertension: a subgroup analysis of a randomized, double-blind, active-controlled trial. Zhu DL; Gao PJ; Liu SW; Jeong MH; Mattheus M; Birgit V Chin Med J (Engl); 2013 Nov; 126(21):4072-7. PubMed ID: 24229676 [TBL] [Abstract][Full Text] [Related]
32. Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild to moderate hypertension. Minami J; Furukata S; Ishimitsu T; Matsuoka H Int Heart J; 2009 Jan; 50(1):85-93. PubMed ID: 19246849 [TBL] [Abstract][Full Text] [Related]
33. Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension. Kjeldsen SE; Schmieder RE; Unger T; Mancia G Curr Med Res Opin; 2010 Apr; 26(4):879-87. PubMed ID: 20144138 [TBL] [Abstract][Full Text] [Related]
34. The effects of telmisartan alone or in combination with hydrochlorothiazide on morning home blood pressure control: the SURGE 2 practice-based study. Redon J; Bilo G; Parati G; Blood Press; 2013 Dec; 22(6):377-85. PubMed ID: 23957824 [TBL] [Abstract][Full Text] [Related]
35. [A randomized, double-blind, double-dummy study comparing a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg to telmisartan 80 mg in Chinese hypertensive patients who failed to respond adequately to telmisartan 80 mg]. Chen SX; Zhang J; Chen SL; Chen JZ; Yan XW; Ke YN; DU FH; Zhang CZ; Qin YW; Pu K; Zhu DL Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Apr; 36(4):300-4. PubMed ID: 19100003 [TBL] [Abstract][Full Text] [Related]
36. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring. Lacourcière Y; Neutel JM; Davidai G; Koval S Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201 [TBL] [Abstract][Full Text] [Related]
37. The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2). Parati G; Bilo G; Redon J; Hypertens Res; 2013 Apr; 36(4):322-7. PubMed ID: 23154590 [TBL] [Abstract][Full Text] [Related]
38. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study. Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591 [TBL] [Abstract][Full Text] [Related]
39. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study. Chrysant SG; Chavanu KJ; Xu J Am J Cardiovasc Drugs; 2009; 9(4):241-51. PubMed ID: 19655819 [TBL] [Abstract][Full Text] [Related]
40. Dose response and safety of telmisartan in patients with mild to moderate hypertension. Smith DH; Matzek KM; Kempthorne-Rawson J J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]